HNB
FOLD

Huntington National Bank’s Amicus Therapeutics FOLD Stock Holding History

Huntington National Bank’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14 Hold
1
– – ﹤0.01% 3636
2025
Q4 		$14 Hold
1
– – ﹤0.01% 3549
2025
Q3 		$8 Hold
1
– – ﹤0.01% 3762
2025
Q2 		$6 Sell
1
-39
-98% -$252 ﹤0.01% 3827
2025
Q1 		$326 Sell
40
-296
-88% -$2.74K ﹤0.01% 2539
2024
Q4 		$3.16K Buy
336
+120
+56% +$1.25K ﹤0.01% 2135
2024
Q3 		$2.31K Hold
216
– – ﹤0.01% 2208
2024
Q2 		$2.14K Buy
216
+138
+177% +$1.42K ﹤0.01% 2146
2024
Q1 		$919 Buy
78
+20
+34% +$256 ﹤0.01% 2295
2023
Q4 		$823 Buy
58
+57
+5,700% +$647 ﹤0.01% 2247
2023
Q3 		$12 Hold
1
– – ﹤0.01% 3359
2023
Q2 		$13 Hold
1
– – ﹤0.01% 3309
2023
Q1 		$11 Hold
1
– – ﹤0.01% 3204
2022
Q4 		$12 Hold
1
– – ﹤0.01% 3044
2022
Q3 		$0 Hold
1
– – ﹤0.01% 2128
2022
Q2 		$0 Hold
1
– – ﹤0.01% 2155
2022
Q1 		$0 Hold
1
– – ﹤0.01% 2137
2021
Q4 		$0 Hold
1
– – ﹤0.01% 2103
2021
Q3 		$0 Hold
1
– – ﹤0.01% 1853
2021
Q2 		$0 Sell
1
-737
-100% -$7.19K ﹤0.01% 1771
2021
Q1 		$7K Sell
738
-38
-5% -$588 ﹤0.01% 1403
2020
Q4 		$18K Sell
776
-64
-8% -$1.31K ﹤0.01% 1153
2020
Q3 		$12K Buy
840
+839
+83,900% +$12.2K ﹤0.01% 1181
2020
Q2 		$0 Hold
1
– – ﹤0.01% 1565
2020
Q1 		$0 Hold
1
– – ﹤0.01% 1626
2019
Q4 		$0 Hold
1
– – ﹤0.01% 1722
2019
Q3 		$0 Hold
1
– – ﹤0.01% 1595
2019
Q2 		$0 Buy
+1
New +$13 ﹤0.01% 1640

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Huntington National Bank's FOLD Position: Q1 2026 in Review

Huntington National Bank held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 1 share worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #3636.

Huntington National Bank first reported a position in FOLD in Q2 2019 and has held it in 28 quarters since. The position peaked at $18K in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Huntington National Bank held 1 share of Amicus Therapeutics worth $14 as of Q1 2026.
  • Huntington National Bank left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3636 holding.
  • Huntington National Bank first reported a position in Amicus Therapeutics in Q2 2019 and has held it in 28 quarters since.
  • Huntington National Bank's Amicus Therapeutics position peaked at $18K in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.